SYNBIOTIC SE
NuWays RecommendationRecommendation
Buy
Price Target
€6.00
Upside
197.03%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€2.02
-€0.03 (-1.46%)
Realtime-Data from 23.09.2025 15:44:06
SYNBIOTIC is a buy-and-build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
ISIN
DE000A3E5A59
Market Cap
€11.31M
Enterprise Value
€14.38M
26 week avg vol.
5000
Primar Exchange
Xetra
IPO
2019
Sector
Health Care
Headquarters
Munich, DE
Employees
75
Incorporated
2015
CEO
Daniel Kruse
Website
Free Float
74.00%
NH mgmt GmbH
8.30%
Cancos GmbH
6.50%
Frank Otto
6.10%
HempConsult GmbH
5.10%
KPIs in EUR
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| Sales | 3.86M | 15.92M | 16.55M |
| EBITDA | -7.19M | -1.01M | -1.35M |
| EBIT | -11.75M | -2.13M | -2.43M |
| EPS | -2.12 | -0.30 | -0.34 |
| FCF | -2.94M | -4.33M | -67.10K |
Valuation
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| EV / Sales | 2.93x | 0.00x | 0.00x |
| EV / EBITDA | (1.57x) | 0.00x | 0.00x |
| EV / EBIT | (0.96x) | 0.00x | 0.00x |
| Price / Earnings | (0.95x) | (6.63x) | (5.89x) |
| EV / FCF | (3.84x) | 0.00x | 0.00x |
Downloads
Latest Research
Initiation